These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 11171685

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CXCL13 is an activity marker for systemic, but not cutaneous lupus erythematosus: a longitudinal cohort study.
    Niederkorn A, Frühauf J, Schwantzer G, Wutte N, Painsi C, Werner S, Stradner M, Berghold A, Hermann J, Aberer E.
    Arch Dermatol Res; 2018 Aug; 310(6):485-493. PubMed ID: 29728857
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Low copy numbers of complement C4 and homozygous deficiency of C4A may predispose to severe disease and earlier disease onset in patients with systemic lupus erythematosus.
    Jüptner M, Flachsbart F, Caliebe A, Lieb W, Schreiber S, Zeuner R, Franke A, Schröder JO.
    Lupus; 2018 Apr; 27(4):600-609. PubMed ID: 29050534
    [Abstract] [Full Text] [Related]

  • 6. Late-onset systemic lupus erythematosus in Latin Americans: a distinct subgroup?
    Catoggio LJ, Soriano ER, Imamura PM, Wojdyla D, Jacobelli S, Massardo L, Chacón Díaz R, Guibert-Toledano M, Alvarellos A, Saurit V, Manni JA, Pascual-Ramos V, Silva de Sauza AW, Bonfa E, Tavares Brenol JC, Ramirez LA, Barile-Fabris LA, De La Torre IG, Alarcón GS, Pons-Estel BA, Grupo Latino Americano De Estudio del Lupus (GLADEL).
    Lupus; 2015 Jul; 24(8):788-95. PubMed ID: 25504653
    [Abstract] [Full Text] [Related]

  • 7. Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus.
    Bonciani D, Antiga E, Bonciolini V, Verdelli A, Del Bianco E, Volpi W, Caproni M.
    Clin Exp Rheumatol; 2016 Jul; 34(1):76-81. PubMed ID: 26742563
    [Abstract] [Full Text] [Related]

  • 8. Serum phosphatidylserine-specific phospholipase A1 as a novel biomarker for monitoring systemic lupus erythematosus disease activity.
    Sawada T, Kurano M, Shirai H, Iwasaki Y, Tahara K, Hayashi H, Igarashi K, Fujio K, Aoki J, Yatomi Y.
    Int J Rheum Dis; 2019 Nov; 22(11):2059-2066. PubMed ID: 31468739
    [Abstract] [Full Text] [Related]

  • 9. Levels of soluble Fas/APO-1/CD95 in systemic lupus erythematosus and juvenile rheumatoid arthritis.
    Knipping E, Krammer PH, Onel KB, Lehman TJ, Mysler E, Elkon KB.
    Arthritis Rheum; 1995 Dec; 38(12):1735-7. PubMed ID: 8849344
    [Abstract] [Full Text] [Related]

  • 10. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 11. Severe vitamin D deficiency increases the risk for moderate to severe disease activity in Chinese patients with SLE.
    Gao CC, Liu SY, Wu ZZ, Li TF, Gao GM, Liu ZS, Zheng ZH.
    Lupus; 2016 Oct; 25(11):1224-9. PubMed ID: 26921268
    [Abstract] [Full Text] [Related]

  • 12. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J, Uher M, Svobodová R, Olejárová M, Hušáková M, Ciferská H, Hulejová H, Tomčík M, Šenolt L, Vencovský J.
    Arthritis Res Ther; 2015 Nov 25; 17():341. PubMed ID: 26608564
    [Abstract] [Full Text] [Related]

  • 13. Clinical profile and direct medical cost of care of adults presenting with systemic lupus erythematosus in Italy.
    Doria A, Iaccarino L, La Montagna G, Mathieu A, Piga M, Galeazzi M, Iuliano A, Maurel FB, Garofano AM, Perna AG, Porcasi RE.
    Clin Exp Rheumatol; 2015 Nov 25; 33(3):375-84. PubMed ID: 26005879
    [Abstract] [Full Text] [Related]

  • 14. Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.
    Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW, UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.
    Arthritis Rheum; 2012 Jul 25; 64(7):2356-65. PubMed ID: 22294381
    [Abstract] [Full Text] [Related]

  • 15. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials.
    Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups.
    Arthritis Rheum; 2013 Aug 25; 65(8):2143-53. PubMed ID: 23754628
    [Abstract] [Full Text] [Related]

  • 16. Complete urological evaluation including sperm DNA fragmentation in male systemic lupus erythematosus patients.
    Tiseo BC, Bonfá E, Borba EF, Munhoz GA, Wood G, Srougi M, Silva CA, Cocuzza M.
    Lupus; 2019 Jan 25; 28(1):59-65. PubMed ID: 30509155
    [Abstract] [Full Text] [Related]

  • 17. Anti-dsDNA titre in female systemic lupus erythematosus patients: relation to disease manifestations, damage and antiphospholipid antibodies.
    Gheita TA, Abaza NM, Hammam N, Mohamed AAA, El-Gazzar II, Eissa AH.
    Lupus; 2018 Jun 25; 27(7):1081-1087. PubMed ID: 29460701
    [Abstract] [Full Text] [Related]

  • 18. High-dose cyclophosphamide without stem cell transplantation in systemic lupus erythematosus.
    Petri M, Jones RJ, Brodsky RA.
    Arthritis Rheum; 2003 Jan 25; 48(1):166-73. PubMed ID: 12528116
    [Abstract] [Full Text] [Related]

  • 19. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H, Wetterö J, Skogh T, Sjöwall C.
    Transl Res; 2013 Nov 25; 162(5):287-96. PubMed ID: 23916811
    [Abstract] [Full Text] [Related]

  • 20. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance.
    Hanly JG, McCurdy G, Fougere L, Douglas JA, Thompson K.
    J Rheumatol; 2004 Nov 25; 31(11):2156-62. PubMed ID: 15517627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.